Fibronectin Type III Domain Containing Protein 1 (FNDC1)
[Edit]AGS8; Activation-associated cDNA protein; Expressed in synovial lining protein
Ags8 was induced in response to rat ventricular ischemia, but not tachycardia, hypertrophy, or failure. Hypoxia induced Ags8 mRNA in isolated adult ventricular cardiomyocytes, but not in rat aortic smooth muscle cells, endothelial cells, or cardiac fibroblasts. The bioactivity of Ags8 was independent of guanine nucleotide exchange by G protein-alpha. Ags8 appeared to interact directly with the G protein-beta and -gamma subunits to promote G protein signaling.expression in heart, lung, skeletal muscle, kidney, pancreas, ovary, spinal cord, and fetal liver, low expression in spleen, testis, and adult and fetal brain, and no expression in liver. Within specific brain regions, expression was moderate in caudate nucleus and low in corpus callosum and substantia nigra, with little to no expression in all other regions examined.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | ELISA Kit Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | ELISA Kit Customized Service Offer |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Fibronectin Type III Domain Containing Protein 1 (FNDC1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Fibronectin Type III Domain Containing Protein 1 (FNDC1) | ELISA Kit Customized Service Offer |
- "Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes."Arthritis Rheum. 41:1356-1364(1998) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and analysis of human chromosome 6." Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
- "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."DNA Res. 8:85-95(2001) [PubMed] [Europe PMC] [Abstract]
- "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
- "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
- "MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-beta and pro-inflammatory cytokines."Exp. Dermatol. 14:709-718(2005) [PubMed] [Europe PMC] [Abstract]